Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
More translational research is needed to evaluate its efficacy on human reward system related disorders
Studies involving 2,569 patients show berberine effectively supports healthy blood sugar, cholesterol, triglycerides, and blood pressure
This dual action makes it an effective option for individuals struggling with obesity or those who need to lose weight to manage their diabetes better
Zingg, J.M., Azzi, A., Meydani, M., 2008a
Wienert et al., 2018)